A DRUG-RESISTANT ASSAY CAN BETTER DIRECT THE NEED FOR ADALIMUMAB DOSE-ESCALATION AFTER INDUCTION THERAPY IN ANTI-TNF NAÏVE PATIENTS WITH CROHN’S DISEASE
Gitte Moors 1
Bram Verstockt 1
Sumin Bian 2
Sophie Tops 3
Vera Ballet
Gert Van Assche
Severine Vermeire
Ann Gils
Marc Ferrante
1 University Hospitals Leuven,Department of Gastroenterology and Hepatology,Leuven,Belgium
2 KU Leuven,Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences,Leuven,Belgium
3 KU Leuven,Laboratory
Conference
25th UEG Week 2017
Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at office@ueg.eu